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THE SCIENCE OF ADDICTION: RESEARCH AND
PUBLIC HEALTH PERSPECTIVES
RICHARD A. MILLSTEIN, J.D.*
ALAN I. LESHNER, PH.D.**
INTRODUCTION
Drug abuse and addiction are among the most serious and costly
problems facing our society. Fortunately, advances in science made
over the last several decades have dramatically increased our under-
standing of these disorders and ledto the development of effective
strategies for their prevention and treatment. This article focuses on
the biological, behavioral, and social mechanisms of drug abuse and
addiction and their implications for prevention, treatment, and
policy.
Drug abuse and addiction are among the most serious and costly
problems facing our society. The estimated cost of illegal drugs alone
is $110 billion a year.1 When the costs of alcohol abuse and addiction
are added, this estimate comes to $276 billion a year. 2 And these
numbers exclude the costs of nicotine.3 These problems are very
costly to address, and impact every sector of society. As Figure 1' illus-
trates, this pervasiveness is seen in virtually every domain.5
In addition to being costly, Americans consistently consider drug
abuse to be a pressing issue, according to public surveys of national
concerns throughout the 1980s and 1990s. 6 Nonetheless, despite
* Mr. Millstein is the Deputy Director of the National Institute on Drug Abuse, at the
National Institutes of Health.
** Dr. Leshner is the Director of the National Institute on Drug Abuse, at the National
Institutes of Health.
1. See Henrick Harwood et al., The Economic Costs of Alcohol and Drug Abuse in the United
States, 1992: Executive Summary (visited Sept. 20, 1999) <http://www.nida.nih.gov/
EconomicCosts/Chapterl.html#1.10> [hereinafter Economic Costs of Alcohol and Drug Abuse:
Executive Summary].
2. See id.
3. See NIDA Infofax: Costs to Society (visited Sept. 20, 1999) <http://www.nida.nih.gov/
Infofax/costs.html>.
4. See generally, NATIONAL INSTITUTE ON DRUG ABUSE AND NATIONAL INSTITUTE ON AL-
COHOL ABUSE AND ALCOHOLISM, THE ECONOMIC COSTS OF ALCOHOL AND DRUG ABUSE IN THE
UNITED STATES (Sept. 1998).
5. See Economic Costs of Alcohol and Drug Abuse: Executive Summary, supra note 1.
6. See Bureau of Justice Statistics, Sourcebook of Criminal Justice Statistics: Public Attitudes
Toward Crime and Criminal Justice-Related Topics (visited Oct. 27, 1999) <http://
www.albany.edu/sourcebook/1995/toc-2.html>; Bureau of Justice Statistics, Drug and
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FIGURE 1: ECONOMIC COSTS OF SUBSTANCE ABUSE
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these two major reasons justifying attention, there are barriers to giv-
ing these issues the attention they merit. Much of this is due to the
belief that addicts "did it to themselves," and thus are undeserving of
care, let alone compassion.
7
The fact is that drug abuse and addiction affect everybody, either
directly or indirectly. Some seventy million Americans have used an
illegal drug at some time in their lives.8 Because of this pervasiveness,
everyone believes he or she is an expert. Because so many people
have direct or indirect contact with this phenomenon, they approach
it from an intuitive, heavily ideological, and moralistic point of view.
Indeed, there are ideologies galore about drug abuse and addiction
that much too frequently drive the responses to this problem. Fortu-
nately, we also have scientific data.
Over the last two decades, advances in science have totally revolu-
tionized our fundamental understanding of drug abuse and addic-
tion.9 Hopefully, those changes will bring to bear a more rational
Crime Facts: Public Opinion About Drugs (visited Oct. 27, 1999) <http://www.ojp.usdoj.gov/
bjs/dcf/poad.htm>.
7. See An Interview with Alan L Leshner, Ph.D. (visited Sept. 27, 1999) <wysiwyg://99/
http://www.pbs.org/wnet/closetohome/science/html/leshner.html> [hereinafter Inter-
view with Alan L Leshner, Ph.D.].
8. See The National Drug Control Strategy: Fewer Americans are Using Illegal Drugs (visited
Sept. 21, 1999) <http://www.njrs.org/htm/chapter2.htm#notel>.
9. See Interview with A. Thomas McLellan (visited Sept. 27, 1999) <wysiwyg://87/http://
www.pbs.org/wnet/closetohome/treatment/html/mclellan.html> [hereinafter Interview
with A. Thomas McLellan]; Mona W. Brown & Sheryl Massaro, Scientists Identify Brain Systems
Involved in Drug Craving (visited Sept. 21, 1999) <http://www.nih.gov/news/pr/oct96/
nida-14.htm> [hereinafter Scientists Identfy Brain Systems Involved in Drug Craving].
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approach to this problem, not only at a national level, but at an indi-
vidual level as well.
The slogan of the Partnership for a Drug-Free America, "Drug
abuse is a preventable behavior. Drug addiction is a treatable dis-
ease,"1" is both a very simple and a very sophisticated statement. Drug
abuse is a decision, a voluntary decision, someone makes and, there-
fore, it is a voluntary, preventable behavior.1 At the same time addic-
tion is a qualitatively different state. It is, in fact, a disease, and it is a
treatable disease.1 2
Whether you begin from a focus on prevention or on treatment,
ultimately you need to start out with the question, "Why do people use
drugs in the first place?" Scientists have devoted a tremendous
amount of effort to this.' 3 Not surprisingly, people speak very fre-
quently about risk.
Part I of this Article examines the factors which are understood to
lead to drug use.14 Part II explains the results of recent studies that
show the effects of drug use, both long-term and short-term, on the
brain. 5 Part III discusses the importance of memory in addiction, 6
while Part IV recommends treatment approaches based on the science
of addiction. 17
I. FACTORS LEADING To DRUG USE
There are over seventy risk factors posited for drug abuse and
addiction." They operate at the individual, peer, family, and commu-
nity levels.1" The risk factors for drug abuse and addiction are the
same risk factors as for many other behavior problems,2" as shown in
Figure 2.
10. Drug-Free Resource Net: Partnership for a Drug-Free America (visited Sept. 21, 1999)
<http://www.drugfreeamerica.org/under.html>.
11. See Addiction Is a Brain Disease (visited Sept. 21, 1999) <http://www.usia.gov/jour-
nals/itgic/0697/ijge/gj-2.htm> [hereinafter Addiction Is a Brain Disease].
12. See id.
13. See Robert J. Pandina, Risk and Protective Factor Models in Adolescent Drug Use: Putting
Them to Work for Prevention (visited Sept. 21, 1999) <http://www.nida.nih.gov/MeetSum/
CODA/Risk.html> [hereinafter Risk and Protective Factor Models in Adolescent Drug Use].
14. See infra footnotes 18-41 and accompanying text.
15. See infta footnotes 42-94 and accompanying text.
16. See infra footnotes 95-107 and accompanying text.
17. See infra footnotes 108-128 and accompanying text.
18. See Addiction Is a Brain Disease, supra note 11.
19. See id.
20. See id.
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FIGURE 2: RISK FACTORS FOR DRUG ABUSE AND ADDICTION
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The problem with an excessive focus on risk is that risk is a
probability statement.2 1 It predicts that people with certain character-
istics are more or less likely to have one of these negative outcomes,
such as drug use.22 However, it does not reveal the behavioral out-
come in any particular individual.2 Moreover, the majority of people
who have the majority of those risk factors never use drugs.24 There-
fore, a focus on risk is not enough.
For these reasons, prevention researchers in the last few years
have placed a far greater emphasis on what are called protective, or
resiliency factors, 25 to explain what protects people who have a tre-
mendous number of risk factors from using drugs.26 The most well
known protective factor is family involvement in the life of the child.27
This is not family involvement just in the child's drug use. 28 Accord-
21. See id.
22. See id.
23. See id.
24. See id.
25. See Risk and Protective Factor Models in Adolescent Drug Use, supra note 13.
26. See id.
27. See Meyer Glantz, The Application of Resiliency and Risk Research to the Development of
Preventive Interventions (visited Sept. 21, 1999) <http://www.nida.nih.gov/ResilandRisk
WG/ResilandRiskWG.html>.
28. See id.
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ingly, a lot of prevention programs have incorporated family strength-
ening approaches. 29
While protection and risk tell you about the probability that
someone will engage in a specific behavior, they do not tell you very
much about why the individual uses drugs."0 To simplify, we posit two
very different reasons why people take drugs. They are dichotomous,
and reflect different distributions of people.
One group of young people uses drugs simply for the sensation of
it.31 These people are novelty seekers.3 2 Theyjust want to have a new
experience, be perceived as "cool," and feel good. 3 A second, sepa-
rate group of people feels terrible in the first place, and uses drugs to
cope with their situation, "normalize" themselves, and feel better than
they feel.34 They "medicate" themselves with illicit drugs the way
others use -anti-depressants or anti-anxiety drugs.35
Obviously the optimal prevention and treatment strategies are
vastly different for those two groups of people.36 However, prevention
programming has focused almost exclusively on the first group, the
attention seeker, and has not paid much attention to the second. 7
The problem with self-medication is that although drugs initially do
make you feel better, over time they compound the problem,38 not
just because they affect lifestyle but because they act as depressants
instead of antidepressants.
Regardless of which reason someone is using drugs, he or she is
doing it in order to modify mood, perception, and emotional state.39
There is really only one way to do that. Drugs modify mood, percep-
tion, and emotional state because they modify brain function.4" Sci-
ence has taught us that a major reason why people take a drug is
because they like what it does to their brain-initially at least.
41
29. See id.
30. See Scientific Exchange: Child's Drug Use Can Go Way Beyond 'Recreational' (visited Sept.
21, 1999) <http://www.nida.nih.gov/International/INVESTWinter99/INVEST3.html>.
31. See id.
32. See id.
33. See id.
34. See id.
35. See id.
36. See id.
37. The normal preventive programs that "educate about the harmful effects of drugs
on their bodies" and seek to teach "alternative ways of having fun" to resist the temptation
of drugs are not effective prevention programs for young people medicating themselves to
feel better. Id.
38. See id.
39. See Addiction Is a Brain Disease, supra note 11.
40. See id.
41. See Interview with Alan L Leshner, Ph.D., supra note 7.
1999]
JOURNAL OF HEALTH CARE LAW & POLICY
II. EFFECTS OF DRUGS TO THE BRAIN
A. The Immediate Effects of Drug Use on the Brain
We no longer need to use inexact metaphors of eggs in a frying
pan. A study at the Massachusetts General Hospital utilizing func-
tional Magnetic Resonance Imaging (MRI) brain scans provides a
modern day depiction of your brain on drugs.4 2 MRI permits you lit-
erally to look into the brain of a living, breathing, awake human being
while that individual is experiencing cocaine,43 and to see the "signa-
ture" in the brain of the drug experience as compared to that of the
same individual given an infusion of saline.44 The MRI ,in the Massa-
chusetts General Hospital study was an aggregate over a drug experi-
ence.45 The nucleus accumbens, an area at the base of the brain that
is very important in drug abuse, not only because it is in an -area that is
activated during any pleasurable experience,46 but also because every
drug of abuse has an effect on it,47 showed increased activity.4"
Once imaging technologies became available, essentially only
within the last six to eight years, it enabled us to examine different
areas of the brain that had not been looked at before. Most of drug
abuse research had focused at the base of the brain, but once these
technologies became available, researchers knew to look at areas like
the amygdala,49 which is involved in emotional memory.
Now we know, in fact in excruciating detail, why people like to
take drugs. What happens when you take a drug like cocaine, is that it
literally concentrates at the base of the brain in the nucleus accum-
bens, 50 and causes the release of a chemical neurotransmitter called
dopamine.5 ' See Figure 3.
42. See generally Hans C. Breiter et al., Acute Effects of Cocaine on Human Brain Activity and
Emotion, 19 NEURON 591 (1997) (discussing the investigation of cocaine-induced euphoria
and craving using functional magnetic resonance imaging (fMRI)).
43. See id.; see also NIDA News Releases: Preventing and Treating Heroin Use Is Focus of Na-
tional Research Conference (visited Sept. 21, 1999) <http://www.nida.nih.gov/MedAdv/Mas-
yr97b.html#9-25> [hereinafter Preventing and Treating Heroin Use Is Focus of National Research
Conference].
44. See Breiter, supra note 42, at 591.
45. See Preventing and Treating Heroin Use Is Focus of National Research Conference, supra
note 43.
46. See id. See also Breiter, supra note 42, at 602.
47. See Preventing and Treating Heroin Use Is Focus of National Research Conference, supra
note 43.
48. See id. See also Breiter, supra note 42, at 602.
49. See Anna Rose Childress, Ph.D. et al., Limbic Activation During Cue-Induced Cocaine
Craving, 156 AM.J. PSYCHIATRY 11, 15 (1999).
50. See Addiction Is a Brain Disease, supra note 11.
51. See id.
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FiGuRE 3: EFFECT OF ACUTE COCAINE ON EXTRACELLULAR DOPAMINE
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Although each has its own idiosyncratic mechanisms of action,
every drug of abuse causes a spike in dopamine levels in the brain.5 2
Researchers are starting to believe that this may be a part of the com-
mon essence of abuse and of addiction. 53 It is true that every pleasur-
able experience causes at least a small increase in dopamine.5 4
Dopamine is needed for the normal experience of pleasure.5 5 Eating,
having sex, or watching a movie-all increase dopamine.56 But taking
cocaine causes, not just a small increase, but a big spike.5 7 That big
spike is perceived as very pleasurable. 5' However, it is not very long
lasting, so people want to repeat it. Animal studies assist researchers
in understanding these effects.5 9 For example, a human being binge-
ing on crack cocaine is trying to produce that spike over and over.
60
By comparison, you do not binge on methamphetamine. 6 1 Both co-
caine and methamphetamine produce a very rapid rise in dopamine,
and with cocaine the increase falls off rapidly,6 2  while with
methamphetamine it falls off very slowly.
63
52. See id.
53. See id. (stating that the "positive experience of drugs comes through the
mesolimbic-dopamine pathway.").
54. See id.
55. See id.; Interview with Alan L Leshner, Ph.D., supra note 7.
56. See Addiction Is a Brain Disease, supra note 11; Interview with Alan I. Leshner, Ph.D.,
supra note 7; Childress, supra note 49, at 12.
57. See Interview with Alan L Leshner, Ph.D., supra note 7.
58. See id.
59. See id.; Addiction Is a Brain Disease, supra note 11.
60. See Addiction Is a Brain Disease, supra note 11.
61. See id. But see Una D. McCann et al., Reduced Striatal Dopamine Transporter Density in
Abstinent Methamphetamine and Methcathinone Users: Evidence from Positron Emission Tomogra-
phy Studies with [1 1C]WN-35,428, 18 J. NEUROSCIENCE 8417, 8417 (1998).
62. See Addiction Is a Brain Disease, supra note 11.
63. See id.
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Dopamine, of course, is not the sole explanatory phenomenon.
There is also a role for serotonin,64 and other neurotransmitters.65
However, dopamine is intimately involved with the core of this phe-
nomenon of drug taking.66
B. The Long-Term Effects of Drugs on the Brain
People take drugs because they like this euphoria. The problem
is that, over time, prolonged drug use actually changes the brain in
fundamental and long-lasting ways-even persisting long after the in-
dividual has stopped taking drugs. Initially drugs produce one kind of
effect. Over time, they produce a different effect.
Researchers are now clearly seeing the long-lasting effects that
drugs can have on the brain and how these may have lasting effects on
an individual's emotional responses and on his or her learning and
memory capacity.67  For example, MDMA,68  or Ecstasy, and
methamphetamine both are becoming increasingly popular with
young adults who attend organized all night social gatherings or
"raves."69 Based on animal studies, both drugs have long been
thought to be neurotoxic at doses similar to those being used by these
young adults,7 ° but direct evidence in humans was lacking.71 Re-
cently, alarming data filled that research gap.72
64. See Steven Stocker, Cocaine's Pleasurable Effects May Involve Multiple Chemical Sites (vis-
ited Sept. 27, 1999) <http://www.nida.nih.gov/NIDANotes/NNVoll4N2/Cocaine.html>.
65. See id. (defining neurotransmitters as chemicals released by neurons to send
messages to other neurons within their vicinity).
66. See id.
67. See Long-Term Brain Injury From Use of "Ecstasy" (visited Sept. 21, 1999) <http://
www.nida.nih.gov/MedAdv/99/NR-614b.html> [hereinafter Long-Term Brain Injury From
Use of "Ecstasy "]. See generally U.D. McCann et al., Positron Emission Tomographic Evidence of
Toxic Effects of MDMA ("Ecstasy") on Brain Serotonin Neurons in Human Beings, 352 LANCET
1433 (1998).
68. See McCann, supra note 67, at 1433 (defining MDMA .as (±)3,4-methylenediox-
ymethamphetamine). See also Long-Term Brain Injury From Use of "Ecstasy," supra note 67.
69. See Popular Rave Drug "Ecstasy" Impairs Memory, Apparently Related To Brain Damage
(visited Sept. 21, 1999) <http://www.nida.nih.gov/MedAdv/98/MA-1221.html> [hereinaf-
ter Popular Rave Drug "Ecstasy" Impairs Memory].
70. See McCann, supra note 67, at 1433; McCann, supra note 61, at 8417; Long-Term
Brain Injury From Use of "Ecstasy," supra note 67.
71. See McCann, supra note 61, at 8418; McCann, supra note 67, at 1433 (describing
previous studies of human MDMA users using indirect markers to determine possible brain
injury).
72. See Popular Rave Drug "Ecstasy" Impairs Memory, supra note 69. See generally McCann,
supra note 61; McCann, supra note 67.
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PET7" scans from George Ricaurte's laboratory atJohns Hopkins
University in Baltimore74 showed images of two human brains, one of
an individual who has never used Ecstasy and the other of an individ-
ual who had used Ecstasy heavily for an extended period but was absti-
nent from drugs for at least three weeks prior to the study.75
Researchers could clearly see that the brain of the Ecstasy user had
been significantly altered. The specific parameter measured was the
brain's ability to bind the chemical neurotransmitter serotonin.76 Se-
rotonin is critical to normal experiences of mood, emotion, pain, and
a wide variety of other behaviors.77 The PET scan showed a decrease
in the Ecstasy user's ability to remove this important neurotransmitter
from the intracellular space,78 thereby amplifying its effects within the
brain. This decrease lasts at least three weeks after the individual has
stopped using Ecstasy. 79 Given serotonin's critical role in many behav-
ioral characteristics," one can speculate that this abnormality of the
serotonin system might be responsible for some of Ecstasy's long-last-
ing behavioral effects.81
Researchers can also view the long-lasting effects that drugs can
have on the brain. Dr. Ricaurte and his colleagues82 examined
dopamine transporter binding in four different adults: a non-drug
user; a chronic methamphetamine user who was drug-free for about
three years when this image was taken; a chronic methcathinone8"
abuser who was also drug free for about three years; and an individual
73. See McCann, supra note 67, at 1433 (defining PET as positron emission tomogra-
phy, a neuroimaging technique that makes it "possible to assess the status of chemically-
defined populations of neurons in the living human brain.").
74. See generally McCann, supra note 67.
75. See id. at 1434.
76. See id. at 1433 (stating that the status of brain serotonin (5-HT), 5-hydroxy-
indoleacetic acid, neurons were investigated in MDMA users).
77. See FRANKJ. AYD, JR., LEXICON OF PSYCHIATRY, NEUROLOGY, AND THE NEUROSCIENCES
581 (David C. Retford ed. 1995) (stating that serotonin is involved in "pain perception,
aggressive and impulsive behavior, anxiety, sleep, circadian rhythms, sexual behavior, hor-
mone secretion, thermoregulation, cardiovascular function, motor activity, food intake,
and mood." Serotonin has also been implicated in disorders such as "anxiety, depression,
migraine, and epilepsy.").
78. See McCann, supra note 67, at 1436 (finding that "decreases in 5-HT transporter
binding positively correlated with extent of previous MDMA use.").
79. See id.; Popular Rave Drug "Ecstasy" Impairs Memory, supra note 69.
80. See supra note 77 and accompanying text.
81. See, e.g. McCann, supra note 67, at 1437 (stating that depression, anxiety, memory
disturbance, and other neuropsychiatric disorders may be a consequence of disorders in-
volving brain 5-HT).
82. See McCann, supra note 61.
83. See generally McCann, supra note 61.
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newly diagnosed with Parkinson's Disease. 4 When compared with the
control, non-drug user, researchers observed a significant loss in the
brain's ability to transport dopamine back into brain cells.8 5
Dopamine function is critical to emotional regulation, is involved in
the normal experience of pleasure, and is involved in controlling an
individual's motor function. 6 Thus, this long-lasting impairment in
dopamine function might account for some of the behavioral dysfunc-
tions that persist after long-term methamphetamine use.8 7
What is believed to occur in addiction is that an individual volun-
tarily begins to use drugs and then, at some point, something hap-
pens.8 8 A metaphorical "switch" flips, in reality a cascade of
biochemical events at the molecular, cellular, and systems levels, at
different times for different people based on biological and other fac-
tors, and an individual moves from a state of voluntary drug use to
become a compulsive drug user.8 9 Compulsive drug use is the essence
of addiction: compulsive, often uncontrollable, drug craving, seeking,
and use in the face of negative consequences."' It is this compulsion
that is responsible for the disruption, crime, and other negative corre-
lates of drug use that follow in its wake. 1
Because addiction comes about as a result of what drugs do to the
brain, and causes these long-lasting changes, at its core, addiction is a
brain disease.9 2 It is, however, not that simple. Drug addiction is not
just a brain disease. 3 There are contributions of biology, behavior,
and environment.
9 4
84. See id.
85. See id.
86. See Addiction Is a Brain Disease, supra note 11.
87. See McCann, supra note 61, at 8421.
88. See Scientists Identify Brain Chemicals Involved in "Switching On" Cocaine Addiction (vis-
ited Sept. 21, 1999) <http://www.nida.nih.gov/MedAdv/99/NR-915.html> [hereinafter
Scientists Identify Brain Chemicals Involved in "Switching On" Cocaine Addiction].
89. See generally Max B. Kelz et al., Expression of the Transcription Factor AFosB in the Brain
Controls Sensitivity to Cocaine, 401 NATURE 272 (1999).
90. See Interview with Alan L Leshner, Ph.D., supra note 7.
91. The "[c]osts of crime attributed to illicit drug abuse were estimated at $59.1 billion,
and costs of crime attributed to alcohol abuse were estimated at $19.7 billion. These costs
include reduced earnings due to incarceration, crime careers, and criminal victimization;
and the costs of criminal justice and drug interdiction." Economic Costs of Alcohol and Drug
Abuse: Executive Summary, supra note 1.
92. See Addiction Is a Brain Disease, supra note 11.
93. See id.
94. See id.
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III. THE MEMORY OF DRUGS
In Alcoholics Anonymous they say that alcoholics need to avoid
the "people, places, and things" that surrounded their initial alcohol
use because these people, places, and things will cause relapse.9 5 In-
terestingly, it is only relatively recently that drug abuse researchers
have also begun to focus on memory as an important part of addic-
tion.9 6 That is because drug taking is a learned behavior, a condi-
tioned phenomenon, where all of the contextual stimuli that
surround initial drug use literally become conditioned to it, and then
exposure to those cues all by itself can elicit phenomenal craving and
therefore relapse.
9 7
Figure 4 illustrates the results of a University of Pennsylvania
study.98 The study measured craving in cocaine addicts presented
with either a nature video or with what is called a cocaine video, which
is a depiction of cocaine paraphernalia, powder, and somebody pre-
paring to use cocaine.9 9 After being exposed to the neutral stimuli,
not surprisingly, there is no craving.10 0 But after merely viewing the
cocaine video, research subjects experienced phenomenal craving.1""
FIGURE 4: CRAVING INDUCTION IN PET SETTING
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4.
3.
Change in
Craving 2
Neutral Cocaine
Stimuli
The work of Anna Rose Childress, published in the January 1999
issue of the American Journal of Psychiatry1"2 illustrates the memory of
drugs. A tremendous activation occurs in both the amygdala, the area
95. Interview with Alan L Leshner, Ph.D., supra note 7. See also Scientists Identify Brain
Systems Involved in Drug Craving, supra note 9.
96. See Scientists Identify Brain Systems Involved in Drug Craving, supra note 9. See generally
Childress, supra note 49.
97. See id.
98. See generally Childress, supra note 49.
99. See id. at 12.
100. See id. at 13.
101. See id.
102. See id.
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involved in emotional memory, 10 3 and in the anterior cingulate,
which is involved in cognitive processing and memory processing.104
This is a biobehavioral phenomenon. It shows the brain's signature of
craving in a living, breathing person, compared to a non-craving state.
This demonstrates that addiction is a disease in which the brain has
become conditioned to the surrounding variables. This is a brain dis-
ease that has literally embedded within it behavioral and social con-
text aspects.
10 5
When dealing with addicted people, one is dealing with people
who are in a different brain state. 106 This compulsive behavior is real,
is biologically based, and is an illness. The compulsion that character-
izes addiction comes about because something has been changed in
the addict's brain.
10 7
IV. TREATMENT FOR DRUG USE
A major task for treatment is to either change the brain back or
compensate in some way for that brain change.1 08 As drug addiction
is a biobehavioral disorder, the best treatments will attend to all as-
pects of the addiction: the biological, the behavioral, and the social
context aspects simultaneously. 0o
Figure 5 depicts work performed at the University of Penn-
sylvania by Thomas McLellan and colleagues." 0 This research shows
that combined treatment, pharmacotherapy plus behavioral therapy,
is better than medication alone."' The subjects are heroin addicts
who are on methadone,' 12 so they all are getting a biological treat-
ment." 3 This explains why some of the problem behaviors measured
are at very low levels to start with." 4 Methadone reduces criminality
103. See supra note 49 and accompanying text.
104. See Childress, supra note 49, at 15.
105. See Addiction Is a Brain Disease, supra note 11.
106. See id.
107. See id.
108. See id.
109. See Addiction Is a Brain Disease, supra note 11.
110. See generally A. Thomas McLellan et al., The Effects of Psychosocial Services in Substance
Abuse Treatment, 269 JAMA 1953 (1993).
111. See id. at 1959.
112. See Interview with Alan L Leshner, Ph.D., supra note 7 (describing methadone as the
equivalent of the nicotine patch for heroin addiction; it works by occupying brain recep-
tors that heroin would normally occupy.).
113. See McLellan, supra note 110, at 1954. The study was designed with three treatment
groups, all receiving a methadone dose of at least 60 mg/d. See id. at 1953.
114. See id. at 1958.
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FIGURE 5: METHADONE LEVELS STUDY: TARGET BEHAVIORS AT
SIX-MONTHS, BY LEVEL OF SERVICE
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and needle sharing." 5 The result is a dose response curve in terms of
using heroin, a very systematic step decrease of heroin use, cocaine
use, sharing needles, and illegal acts." 6 An examination of employ-
ment factors, such as the number of days worked, income, and per-
cent of patients working, shows that adding increasing doses of
behavioral treatment makes the biological treatment better." 7
We have in the clinical toolbox a range of very effective drug
treatments." 8 Of course, there is no one size fits all, and they are not
perfect. The National Institute on Drug Abuse 1'9 would not be trying
to improve existing treatments and develop new ones if the existing
drug treatments were perfect. 2 ' The bottom line is that drug addic-
tion can be treated as readily as other diseases with major medications
and behavioral compliance issues.
Understanding drug abuse and addiction from a health perspec-
tive forces society to think about these conditions in fundamentally
different ways. Having a health perspective influences treatment out-
115. See Interview with A. Thomas McLellan, supra note 9.
116. See id.
117. See McLellan, supra note 110, at 1958.
118. See Interview with Alan I. Leshner, Ph.D., supra note 7.
119. The National Institute on Drug Abuse (NIDA) was established in 1974, and became
part of the National Institutes of Health, Department of Health and Human Services in
October 1992. See Dr. Alan I. Leshner, Welcome from the N1DA Director (visited Sept. 27,
1999) <http://wwwnida.nih.gov/NIDAWelcome.html>. NIDA "supports over 85% of the
world's research on the health aspects of drug abuse and addiction." Id.
120. See NIDA's Future (visited Sept. 27, 1999) <http://www.nida.nih.gov/
AboutNIDA.html>.
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come expectations, criminal justice approaches, and drug use pattern
expectations.
12 1
For example, treatment can have a significant impact on drug use
and recidivism in drug abusers within the criminal justice
population.
1 22
Figure 6 depicts the results of a study at the University of Dela-
ware on treatment in prison.' 23 As this chart on eighteen month fol-
low-up shows, although well over sixty percent of untreated drug users
who have been imprisoned revert to both drug use and criminality
within very short periods of time, incorporating treatment into the
incarceration and post-release strategy reduced recidivism by as much
as seventy percent.12" With no aftercare, and just a little bit of AIDS
education, at eighteen months after release seventy percent of the
subjects are back using drugs, 125 and fifty-two percent are back in
FIGURE 6: DELAWARE THERAPEUTIC CONTINUUM ASSESSMENT:
18 MONTH FOLLOW-UP
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40. JiM Arrests**1
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HIV Education Key Crest Key-Crest
Key:
HIV Education - no TC
Key - in-prison TC only
Crest - work release TC only
Key-Crest - both TCs
* Used drugs one or more times during the last 18 months
** One or more new arrests and/or probation violations during
the last 18 months
121. See Interoiew with A. Thomas McLellan, supra note 9.
122. See Robert Mathias, Correctional Treatment Helps Offenders Stay Drug and Arrest Free
(visited Sept. 22, 1999) <http://www.nida.nih.gov/NIDA Notes/NNVo110N4/
Prison.html> (referring to the figure showing the drug-free and arrest-free percentages).
123. See id.
124. See id.
125. See id.
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jail. "' 6 On the other hand, with a comprehensive program, only
twenty-four percent are back using drugs 27 and twenty-nine percent
are back in jail.128
The bottom line is that it is foolish not to treat addicts while they
are in prison, because otherwise many of them will be back. So, not
surprisingly, the biggest advocates for treatment in this country right
now are people in the criminal justice system. From a societal point of
view, getting a handle on crime in this country will require treating
the addicts who are responsible for a large amount of it.
CONCLUSION
We know a tremendous amount about drug abuse and addiction
and what to do about it. The dilemma is that the problems we still
face require more than increasing the understanding of drug abuse
and addiction. Unfortunately, there is a disconnect between the pub-
lic's perception of the nature of this disease and the scientific bases we
have discovered through research. Pervasive misconception about the
nature of drug abuse and addiction have created barriers to its ade-
quate treatment coverage under most health care systems. If we are
going to make any real progress in this country we need to overcome
that disconnect between the scientific facts and the ideology, intui-
tion, and so-called common sense-based approaches to dealing with
this problem. Now that we have the science base, we can in fact
mount a much more rational approach, and science can replace ideol-
ogy, as the foundation for drug abuse and addiction prevention, treat-
ment, and policy strategies. However, we as a society need everyone's
collective will in order to accomplish this.
126. See id.
127. See id.
128. See id.
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